Smart sensors could revolutionize ICU blood sugar management
NCT ID NCT05585801
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether continuous glucose monitors (CGMs) can help ICU patients maintain safe blood sugar levels more effectively than standard finger-stick checks. Researchers will enroll 500 adults undergoing major surgeries like pancreas or liver transplants. The goal is to see if CGMs reduce time spent outside the target glucose range and ease the workload on nurses.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dexcom G6 continuous glucose monitor
What this could lead to
If successful, this could show that continuous glucose monitors are reliable and effective for managing blood sugar in ICU patients, potentially becoming a new standard of care.
What could go wrong
This is a single-center study with 500 patients, and results may not apply to all ICU settings. The device's accuracy in critically ill patients is still unproven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL CARE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute for Clinical and Experimental Medicine
Prague, Czechia